Dr. Petros Grivas, MD at Cleveland Clinic discusses the evaluation of response to enzalutamide consecutively after disease progression on abiraterone prednisone at ASCO GU 2016 in San Francisco.
Advertisement
[the_ad id="32629"]
Evaluation of response to enzalutamide consecutively after disease progression on abiraterone prednisone
By Editor